Latest Information Update: 30 Jul 2015
At a glance
- Originator DarPharma
- Mechanism of Action Dopamine D1 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 08 Apr 2002 Preclinical trials in Parkinson's disease in USA (unspecified route)